Utah SB0055 mandates health care providers to inform patients about stem cell therapies using placental tissue.

Utah SB0055 requires health care providers to provide written notice to patients before performing stem cell therapies using placental tissue. The notice must include details about the treatment, its FDA approval status, anticipated results, alternative treatments, and potential risks. The bill also mandates that health care providers obtain signed consent from patients before performing the therapy. The notice must be prominently displayed in the provider's office and included in any advertisements for the therapy. The bill takes effect on May 6, 2026.

Utah SB0055 mandates health care providers to inform patients about stem cell therapies using placental tissue.

Utah SB0055 requires health care providers to provide written notice to patients before performing stem cell therapies using placental tissue. The notice must include details about the treatment, its FDA approval status, anticipated results, alternative treatments, and potential risks. The bill also mandates that health care providers obtain signed consent from patients before performing the therapy. The notice must be prominently displayed in the provider's office and included in any advertisements for the therapy. The bill takes effect on May 6, 2026.